MARKET INTRODUCTION
Non-Hodgkin's Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of lymphocytes at multiple stages of maturation. There are approximately 30 types of NHLs with varying pathological, clinical, and genetic features. Chronic Lymphoma (CLL) is a neoplasm of monomorphic small, round lymphocytes of B cell origin in 98% of the cases.
MARKET DYNAMICS
The non-Hodgkin's lymphoma and chronic lymphoma treatment market is driving due to the factors such as increasing awareness among public with respect to the NHL and CLL, increasing number of clinical trials and pipeline products, and rising number of cancers across the world. In addition, development and launch of new products in the developing nations of the world are likely to offer growth opportunities for market players.
MARKET SCOPE
The "Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of non-Hodgkin's lymphoma and chronic lymphoma treatment market with detailed market segmentation by treatment type and cell type. The non-Hodgkin's lymphoma and chronic lymphoma treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in non-Hodgkin's lymphoma and chronic lymphoma treatment market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The non-Hodgkin's lymphoma and chronic lymphoma treatment market is segmented on the basis of treatment type and cell type. Based on treatment type, the market is segmented as chemotherapy, immunotherapy, targeted therapy, radiation and stem cell transplant. On the basis of cell type, the market is segmented into B-Cell and T-Cell.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the non-Hodgkin's lymphoma and chronic lymphoma treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The non-Hodgkin's lymphoma and chronic lymphoma treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting non-Hodgkin's lymphoma and chronic lymphoma treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the non-Hodgkin's lymphoma and chronic lymphoma treatment market in these regions.
MARKET PLAYERS
The report covers key developments in the non-Hodgkin's lymphoma and chronic lymphoma treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from non-Hodgkin's lymphoma and chronic lymphoma treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for non-Hodgkin's lymphoma and chronic lymphoma treatment in the global market. Below mentioned is the list of few companies engaged in the non-Hodgkin's lymphoma and chronic lymphoma treatment market.
The report also includes the profiles of key players in non-Hodgkin's lymphoma and chronic lymphoma treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- F. Hoffmann La-Roche Ltd.
- Johnson and Johnson Services, Inc.
- Bayer AG
- Eli Lilly and Company
- Amgen, Inc.
- Novartis AG
- Gilead
- Kite Pharma, Inc.
- GlaxoSmithKline Plc
- Bristol-Myers Squibb
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. PUBLISHERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market - By Treatment Type
1.3.2 Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market - By Cell Type
1.3.3 Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOMA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOMA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOMA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOMA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOMA TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOMA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. CHEMOTHERAPY
7.3.1. Overview
7.3.2. Chemotherapy Market Forecast and Analysis
7.4. IMMUNOTHERAPY
7.4.1. Overview
7.4.2. Immunotherapy Market Forecast and Analysis
7.5. TARGETED THERAPY
7.5.1. Overview
7.5.2. Targeted Therapy Market Forecast and Analysis
7.6. RADIATION
7.6.1. Overview
7.6.2. Radiation Market Forecast and Analysis
7.7. STEM CELL TRANSPLANT
7.7.1. Overview
7.7.2. Stem Cell Transplant Market Forecast and Analysis
8. NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOMA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - CELL TYPE
8.1. OVERVIEW
8.2. CELL TYPE MARKET FORECASTS AND ANALYSIS
8.3. B-CELL
8.3.1. Overview
8.3.2. B-Cell Market Forecast and Analysis
8.4. T-CELL
8.4.1. Overview
8.4.2. T-Cell Market Forecast and Analysis
9. NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOMA TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Overview
9.1.2 North America Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis
9.1.3 North America Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Treatment Type
9.1.4 North America Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Cell Type
9.1.5 North America Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.1.5.1.1 United States Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.1.5.1.2 United States Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.1.5.2 Canada Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.1.5.2.1 Canada Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.1.5.2.2 Canada Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.1.5.3 Mexico Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.1.5.3.1 Mexico Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.1.5.3.2 Mexico Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.2. EUROPE
9.2.1 Europe Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Overview
9.2.2 Europe Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis
9.2.3 Europe Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Treatment Type
9.2.4 Europe Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Cell Type
9.2.5 Europe Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.2.5.1.1 Germany Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.2.5.1.2 Germany Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.2.5.2 France Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.2.5.2.1 France Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.2.5.2.2 France Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.2.5.3 Italy Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.2.5.3.1 Italy Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.2.5.3.2 Italy Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.2.5.4 Spain Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.2.5.4.1 Spain Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.2.5.4.2 Spain Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.2.5.5 United Kingdom Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.2.5.5.1 United Kingdom Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.2.5.5.2 United Kingdom Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.2.5.6 Rest of Europe Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.2.5.6.1 Rest of Europe Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.2.5.6.2 Rest of Europe Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Overview
9.3.2 Asia-Pacific Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Treatment Type
9.3.4 Asia-Pacific Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Cell Type
9.3.5 Asia-Pacific Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.3.5.1.1 Australia Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.3.5.1.2 Australia Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.3.5.2 China Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.3.5.2.1 China Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.3.5.2.2 China Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.3.5.3 India Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.3.5.3.1 India Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.3.5.3.2 India Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.3.5.4 Japan Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.3.5.4.1 Japan Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.3.5.4.2 Japan Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.3.5.5 South Korea Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.3.5.5.1 South Korea Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.3.5.5.2 South Korea Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.3.5.6 Rest of Asia-Pacific Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.3.5.6.1 Rest of Asia-Pacific Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.3.5.6.2 Rest of Asia-Pacific Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Overview
9.4.2 Middle East and Africa Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Treatment Type
9.4.4 Middle East and Africa Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Cell Type
9.4.5 Middle East and Africa Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.4.5.1.1 South Africa Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.4.5.1.2 South Africa Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.4.5.2 Saudi Arabia Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.4.5.2.1 Saudi Arabia Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.4.5.2.2 Saudi Arabia Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.4.5.3 U.A.E Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.4.5.3.1 U.A.E Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.4.5.3.2 U.A.E Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.4.5.4 Rest of Middle East and Africa Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.4.5.4.1 Rest of Middle East and Africa Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.4.5.4.2 Rest of Middle East and Africa Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Overview
9.5.2 South and Central America Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis
9.5.3 South and Central America Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Treatment Type
9.5.4 South and Central America Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Cell Type
9.5.5 South and Central America Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.5.5.1.1 Brazil Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.5.5.1.2 Brazil Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.5.5.2 Argentina Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.5.5.2.1 Argentina Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.5.5.2.2 Argentina Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
9.5.5.3 Rest of South and Central America Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market
9.5.5.3.1 Rest of South and Central America Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Treatment Type
9.5.5.3.2 Rest of South and Central America Non-Hodgkin's Lymphoma And Chronic Lymphoma Treatment Market by Cell Type
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOMA TREATMENT MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOMA TREATMENT MARKET, KEY COMPANY PROFILES
12.1. F. HOFFMANN LA-ROCHE LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. JOHNSON AND JOHNSON SERVICES, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BAYER AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ELI LILLY AND COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. AMGEN, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NOVARTIS AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GILEAD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. KITE PHARMA, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GLAXOSMITHKLINE PLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BRISTOL-MYERS SQUIBB
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT PUBLISHERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. F. Hoffmann La-Roche Ltd.
2. Johnson and Johnson Services, Inc.
3. Bayer AG
4. Eli Lilly and Company
5. Amgen, Inc.
6. Novartis AG
7. Gilead
8. Kite Pharma, Inc.
9. GlaxoSmithKline Plc
10. Bristol-Myers Squibb
Global Cryolipolysis Machine Market Grow..
According to this latest study, the 2020 growth of Cryolipol..
+1-646-791 7070US (Toll Free)